Anzeige
Meldung des Tages: 0,01 % von 1 BILLIONEN USD = 100 MILLIONEN USD — Und UberDoc ist gerade erst an die Börse gegangen

Supernus Pharmaceuticals News

Aktie
WKN:  A1JX3U ISIN:  US8684591089 US-Symbol:  SUPN Branche:  Pharmazeutika Land:  USA
50,68 $
-0,85 $
-1,65%
43,224 € 10.04.26
Depot/Watchlist
Marktkapitalisierung *
2,42 Mrd. €
Streubesitz
-
KGV
27,60
Index-Zuordnung
-

Supernus Pharmaceuticals News

16.06.25 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. PR Newswire
23.05.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
16.05.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
07.05.24 - PR Newswire
M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America
M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America PR Newswire
28.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
20.04.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
05.03.24 - PR Newswire
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies?
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies? PR Newswire
04.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
19.10.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
02.05.22 - PR Newswire
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults PR Newswire
02.11.21 - PR Newswire
ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS
ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
13.10.21 - PR Newswire
Thinking about buying stock in DatChat, Infosys, Supernus Pharmaceuticals, FuelCell Energy, or Ocugen?
Thinking about buying stock in DatChat, Infosys, Supernus Pharmaceuticals, FuelCell Energy, or Ocugen? PR Newswire
17.06.21 - PR Newswire
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics? PR Newswire
13.04.21 - PR Newswire
Thinking about buying stock in IZEA Worldwide, WiMi Hologram Cloud, Veru, iHeartMedia, or Supernus Pharmaceuticals?
Thinking about buying stock in IZEA Worldwide, WiMi Hologram Cloud, Veru, iHeartMedia, or Supernus Pharmaceuticals? PR Newswire
05.04.21 - PR Newswire
Thinking about trading options or stock in Invitae Corp, Tesla, Supernus Pharmaceuticals, Mohawk Group, or WW International?
Thinking about trading options or stock in Invitae Corp, Tesla, Supernus Pharmaceuticals, Mohawk Group, or WW International? PR Newswire
23.12.20 - PR Newswire
Thinking about buying stock in Ocugen, Kopin Corp, Mogo Inc, Supernus Pharmaceuticals, or eMagin Corp?
Thinking about buying stock in Ocugen, Kopin Corp, Mogo Inc, Supernus Pharmaceuticals, or eMagin Corp? PR Newswire
11.11.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire
01.06.18 - PR Newswire
Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders
Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders PR Newswire
19.09.16 - PR Newswire
Learn how to target a 20% return on Netflix, or get option-trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose
Learn how to target a 20% return on Netflix, or get option-​trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose PR Newswire
12.07.16 - PR Newswire
Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors
Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors PR Newswire

Newssuche

Videos

newspaper
07.04.26 -4,86%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »